Shopping Cart 0
Cart Subtotal
USD 0

Inferior Vena Cava Filters (IVCF)-Medical Devices Pipeline Assessment, 2017

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 2500

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 5000

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 7500
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Inferior Vena Cava Filters (IVCF)-Medical Devices Pipeline Assessment, 2017

Summary

GlobalData's Medical Devices sector report, "Inferior Vena Cava Filters (IVCF)-Medical Devices Pipeline Assessment, 2017" provides an overview of Inferior Vena Cava Filters (IVCF) currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and the number of trials for the key Inferior Vena Cava Filters (IVCF) pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

Extensive coverage of the Inferior Vena Cava Filters (IVCF) under development

The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities

The report reviews the major players involved in the development of Inferior Vena Cava Filters (IVCF) and list all their pipeline projects

The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage

The report provides key clinical trial data of ongoing trials specific to pipeline products

Recent developments in the segment / industry

Reasons to Buy

The report enables you to-

Formulate significant competitor information, analysis, and insights to improve R&D strategies

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Identify and understand important and diverse types of Inferior Vena Cava Filters (IVCF) under development

Develop market-entry and market expansion strategies

Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

In-depth analysis of the product's current stage of development, territory and estimated launch date

READ MORE

Table Of Content

Scope

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 4

1.2 List of Figures 4

2 Introduction 5

2.1 Inferior Vena Cava Filters (IVCF) Overview 5

3 Products under Development 6

3.1 Inferior Vena Cava Filters (IVCF)-Pipeline Products by Stage of Development 6

3.2 Inferior Vena Cava Filters (IVCF)-Pipeline Products by Segment 7

3.3 Inferior Vena Cava Filters (IVCF)-Pipeline Products by Territory 8

3.4 Inferior Vena Cava Filters (IVCF)-Pipeline Products by Regulatory Path 9

3.5 Inferior Vena Cava Filters (IVCF)-Pipeline Products by Estimated Approval Date 10

4 Inferior Vena Cava Filters (IVCF)-Pipeline Products under Development by Companies 11

4.1 Inferior Vena Cava Filters (IVCF) Companies-Pipeline Products by Stage of Development 11

4.2 Inferior Vena Cava Filters (IVCF)-Pipeline Products by Stage of Development 12

5 Inferior Vena Cava Filters (IVCF) Companies and Product Overview 13

5.1 Adient Medical Inc. Company Overview 13

5.1.1 Adient Medical Inc. Pipeline Products & Ongoing Clinical Trials Overview 13

5.2 Contego Medical, LLC Company Overview 14

5.2.1 Contego Medical, LLC Pipeline Products & Ongoing Clinical Trials Overview 14

5.3 Interventional & Surgical Innovations, LLC Company Overview 15

5.3.1 Interventional & Surgical Innovations, LLC Pipeline Products & Ongoing Clinical Trials Overview 15

5.4 Kaleidoscope Company Overview 16

5.4.1 Kaleidoscope Pipeline Products & Ongoing Clinical Trials Overview 16

5.5 Lifetech Scientific (Shenzhen) Co., Ltd. Company Overview 17

5.5.1 Lifetech Scientific (Shenzhen) Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview 17

5.6 Veniti Inc Company Overview 18

5.6.1 Veniti Inc Pipeline Products & Ongoing Clinical Trials Overview 18

5.7 Volcano Corp Company Overview 19

5.7.1 Volcano Corp Pipeline Products & Ongoing Clinical Trials Overview 19

5.8 VueKlar Cardiovascular Ltd Company Overview 20

5.8.1 VueKlar Cardiovascular Ltd Pipeline Products & Ongoing Clinical Trials Overview 20

6 Inferior Vena Cava Filters (IVCF)- Recent Developments 22

6.1 Feb 22, 2017: Change in the B. Braun Management Board 22

6.2 Feb 02, 2017: Boston Scientific Announces Results For Fourth Quarter And Full Year Ended December 31, 2016 22

6.3 Jan 26, 2017: Bard Announces Fourth Quarter Results 23

6.4 Oct 26, 2016: Boston Scientific Announces Results For Third Quarter 2016 24

6.5 Oct 25, 2016: Bard Announces Third Quarter Results 26

6.6 Oct 10, 2016: Professor Ian Meredith To Join Boston Scientific As Executive Vice President And Global Chief Medical Officer 26

6.7 Oct 05, 2016: First Commercial Placements of the Angel Catheter in the United States 27

6.8 Aug 31, 2016: Cook Medical Names Jean-Marc Creissel Vice President of Operations in Greater China 28

6.9 Aug 24, 2016: Bio2 Medical Announces 510(k) Clearance from the FDA for the Angel Catheter, the First Ever Prophylactic Use Indication for a Medical Device for Pulmonary Embolism 28

6.10 Jul 28, 2016: Boston Scientific Announces Results For Second Quarter 2016 29

6.11 Jul 26, 2016: Bard Announces Second Quarter Results 31

6.12 Jul 13, 2016: Boston Scientific Elects Yoshiaki Fujimori to Board of Directors 32

6.13 Jul 01, 2016: Adient Medical Raises USD1.46 Million in Venture Financing 32

6.14 Jun 08, 2016: Boston Scientific Announces Restructuring Program to Support Long-Term Growth and Innovation 32

7 Appendix 34

7.1 Methodology 34

7.2 About GlobalData 37

7.3 Contact Us 37

7.4 Disclaimer 37


List Of Figure

1.2 List of Figures

Figure 1: Inferior Vena Cava Filters (IVCF)-Pipeline Products by Stage of Development 6

Figure 2: Inferior Vena Cava Filters (IVCF)-Pipeline Products by Segment 7

Figure 3: Inferior Vena Cava Filters (IVCF)-Pipeline Products by Territory 8

Figure 4: Inferior Vena Cava Filters (IVCF)-Pipeline Products by Regulatory Path 9

Figure 5: Inferior Vena Cava Filters (IVCF)-Pipeline Products by Estimated Approval Date 10


List Of Table

1.1 List of Tables

Table 1: Inferior Vena Cava Filters (IVCF)-Pipeline Products by Stage of Development 6

Table 2: Inferior Vena Cava Filters (IVCF)-Pipeline Products by Segment 7

Table 3: Inferior Vena Cava Filters (IVCF)-Pipeline Products by Territory 8

Table 4: Inferior Vena Cava Filters (IVCF)-Pipeline Products by Regulatory Path 9

Table 5: Inferior Vena Cava Filters (IVCF)-Pipeline Products by Estimated Approval Date 10

Table 6: Inferior Vena Cava Filters (IVCF) Companies-Pipeline Products by Stage of Development 11

Table 7: Inferior Vena Cava Filters (IVCF)-Pipeline Products by Stage of Development 12

Table 8: Adient Medical Inc. Pipeline Products & Ongoing Clinical Trials Overview 13

Table 9: Absorbable Vascular Filter-Product Status 13

Table 10: Absorbable Vascular Filter-Product Description 13

Table 11: Contego Medical, LLC Pipeline Products & Ongoing Clinical Trials Overview 14

Table 12: Temporary IVC Filter-Product Status 14

Table 13: Temporary IVC Filter-Product Description 14

Table 14: Interventional & Surgical Innovations, LLC Pipeline Products & Ongoing Clinical Trials Overview 15

Table 15: Inferior Vena Cava Filter-Product Status 15

Table 16: Inferior Vena Cava Filter-Product Description 15

Table 17: Kaleidoscope Pipeline Products & Ongoing Clinical Trials Overview 16

Table 18: Reversible IVC Filter-Product Status 16

Table 19: Reversible IVC Filter-Product Description 16

Table 20: Lifetech Scientific (Shenzhen) Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview 17

Table 21: Second Generation Vena Cava Filter-Product Status 17

Table 22: Second Generation Vena Cava Filter-Product Description 17

Table 23: Veniti Inc Pipeline Products & Ongoing Clinical Trials Overview 18

Table 24: VENITI VIDI Vena Cava Filter-Product Status 18

Table 25: VENITI VIDI Vena Cava Filter-Product Description 18

Table 26: Volcano Corp Pipeline Products & Ongoing Clinical Trials Overview 19

Table 27: Lumifi-Crux + IVUS Combo-Product Status 19

Table 28: Lumifi-Crux + IVUS Combo-Product Description 19

Table 29: VueKlar Cardiovascular Ltd Pipeline Products & Ongoing Clinical Trials Overview 20

Table 30: MR-Enhancing Retrievable Vena Cava Filter-Product Status 20

Table 31: MR-Enhancing Retrievable Vena Cava Filter-Product Description 21

Table 32: Glossary 36

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies


Companies

Adient Medical Inc., Contego Medical, LLC, Interventional & Surgical Innovations, LLC, Kaleidoscope, Lifetech Scientific (Shenzhen) Co., Ltd., Veniti Inc, Volcano Corp, VueKlar Cardiovascular Ltd